Document is current
Any future updates will be listed below
-
Authors
She, Bingyang
Sun, Jiajun
Lu, Fang
Lin, Siqi
Liu, Yi
Li, Gaixia
Hu, Yawu
Tang, Weiming
Tan, Rayner
Ong, Jason
Su, Shu
Zhang, Lei
-
Funding
Funding for this research was provided by:
the National Natural Science Foundation of China (No. 82304246)
the Natural Science Foundation of Chongqing (No. CSTB2023NSCQ-MSX0198)
the joint project of the Chongqing Health Commission and Science and Technology Bureau (2024QNXM057)
Kuanren Talent programs of the second affiliated hospital of Chongqing Medical University (202417-16)
National Key R&D Program of China (2022YFC2505100, 2022YFC2505103)
Outstanding Young Scholars Support Program (3111500001)
Epidemiology modeling and risk assessment (20200344)
Xi’an Jiaotong University Young Scholar Support Grant (YX6J004)
- License Information
-
More Information
Article History
Received: 18 October 2024
Accepted: 19 March 2025
First Online: 10 April 2025
Declarations
:
: Ethical approval for this study was obtained from the Human Research Ethics Committee of the Zhuhai Centre for Disease Control and Prevention (CDC) (Ethics documents ID No. [2022] 11). Informed consent was obtained from all participants involved in the study. All experiments on humans and/or the use of human tissue samples were performed in accordance with relevant guidelines and regulations.
: Not Applicable.
: The authors declare no competing interests.
: The questionnaire used in this study was developed specifically for the purposes of this research. The Supplementary Materials include the full study questionnaire and a comprehensive list of substances about which participants were questioned. (See Appendix Codebook)
